Ironwood Pharmaceuticals | IRWD - Ebit

股票价格
3.04
每天变化
-0.19 -5.88%
每月一次
-18.93%
每年
115.60%
Q1 预测
3.27


金融业
股票价格
USD
资产
USD 396.06M
现金及等价物
USD 140.41M
销售成本
USD 29.83M
流动资产
USD 273.84M
流动负债
USD 242.5M
债务
USD 583.99M
EBIT
USD 33.22M
EBITDA
USD 81.81M
员工
267
EPS每股收益
USD -0.01
股本和储备
USD -264.16M
销售毛利
USD 85.24M
债务利息支出
USD 8.74M
利息收入
USD 778K
贷款资金
USD 583.99M
市值
USD 505.6M
净收入
USD 3.19M
营业费用
USD 57.33M
营业利润
USD 33.22M
普通股股本
USD 160K
PE价格收益
204.24
税前利润
USD 68.02M
销售收入
USD 47.71M
销售和管理费用
USD 33.33M
贸易债权人
USD 1.61M
应收帐款人
USD 81.89M


Ebit 更改 日
Acadia Pharmaceuticals USD 17.39M 18.36M 2025-12
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Almirall EUR 30.23M 12.8M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Amarin USD -2.26M 564K 2025-12
Ardelyx USD 5.1M 2.02M 2025-12
Astellas Pharma JPY 134.54B 30.13B 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Charles River Laboratories USD 75.82M 57.98M 2025-12
Coherus Biosciences USD -39.08M 3.65M 2025-12
Esperion Therapeutics USD 85.23M 95.19M 2025-12
Exact Sciences USD -25M 22.85M 2025-09
Halozyme Therapeutics USD -88.41M 306.33M 2025-12
Incyte USD 383.88M 47.44M 2025-12
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Karyopharm Therapeutics USD -26.28M 1.84M 2024-09
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
MacroGenics USD -12.1M 32.26M 2025-12
Moderna USD -857M 597M 2025-12
Myriad Genetics USD -3M 20.3M 2025-12
Pacira USD 3.19M 9.96M 2025-12
PTC Therapeutics USD -81.62M 85.11M 2025-12
Puma Biotechnology USD -2.2M 11.41M 2024-06
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Takeda JPY 257.49B 568.56B 2025-12
Ultragenyx Pharmaceutical USD -114M 56.89M 2025-12
Vanda Pharmaceuticals USD -10.28M 721K 2024-12